Systemic Anti-Cancer Therapy in Synovial Sarcoma: A Systematic Review
Synovial sarcoma (SS) is an aggressive malignancy which accounts for approximately 5–10% of all soft-tissue sarcomas. SS has pathologic and genomic characteristics that define it as a distinct subtype of soft tissue sarcoma (STS). STS subtypes continue to be recognized as distinct entities with spec...
Main Authors: | Richard F. Riedel, Robin L. Jones, Antoine Italiano, Chet Bohac, Juliette C. Thompson, Kerstin Mueller, Zaeem Khan, Seth M. Pollack, Brian A. Van Tine |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/10/11/417 |
Similar Items
-
Testicular Synovial Sarcoma: A Case Report
by: Mejri Nesrine, et al.
Published: (2012-12-01) -
Synovial sarcoma of the maxillary sinus: an extremely rare case with excellent response to chemotherapy
by: Saito S, et al.
Published: (2018-01-01) -
Risk Factors Including Age, Stage and Anatomic Location that Impact the Outcomes of Patients with Synovial Sarcoma
by: Minggui Pan, et al.
Published: (2018-03-01) -
Primary renal sarcoma with morphologic and immunohistochemical aspects compatible with synovial sarcoma
by: Carlos H. Schaal, et al.
Published: (2004-06-01) -
Influence of neoadjuvant chemotherapy on prognosis of patients with synovial sarcoma
by: Yanan Wu, et al.
Published: (2017-05-01)